Brussels, 2nd October 2008
The final report of the Pharmaceutical Forum was presented today in Brussels setting out principles and recommendations on three key challenges in the pharmaceutical landscape. Firstly, how to improve information on diseases and treatments, secondly, how to compare medicines and identify the most effective ones and thirdly how to balance access and reward for innovation within limited healthcare budgets. The Pharmaceutical Forum was co-chaired by Günter Verheugen, Vice-President of the European Commission, and Commissioner Androulla Vassiliou. This meeting marks the end of a 3-year mandate. The Forum brought together Member States and stakeholders, including patient organisations, health professionals, industry and insurers. The final report comprises a set of principles and recommendations to increase cooperation in three key areas.
Vice President Verheugen, responsible for enterprise and industry policy
said: "The Forum's recommendations can lead to important savings and permit a
better reward for pharmaceutical innovation. I call upon industry and national
authorities to help implementing these recommendations to the benefit of the
patients and health care budget."
Information to patients on diseases and treatments
The Forum has adopted recommendations to enhance access to and quality of information, such as:
Member States, payers and patients face the common challenge of containing health care budgets, including pharmaceutical costs, while promoting and sustaining innovation properly. They therefore need to recognize the value of identifying the most effective medicines. The group reached agreement on:
Pricing and reimbursement
Final pricing and reimbursement decisions are usually required before patients can access new health solutions and innovative companies can obtain reward for their research. Although pricing and reimbursement decisions are made by individual Member States, they share the concern on balancing access and reward with limited resources. Concrete recommendations promote:
Member States and stakeholders are invited to implement the recommendations
of the Forum. The Commission will provide support to the strengthening of the
cooperation tools. All background documents related to the work of the
Pharmaceutical Forum are available at: